Low-dose short-term cyclosporine versus etretinate in psoriasis: Improvement of skin, nail, and joint involvement☆
References (56)
- et al.
Cyclosporine in psoriasis: a multicenter dose-finding study in severe plaque psoriasis
J Am Acad Dermatol
(1992) Systemic and local administration of cyclosporine in the treatment of psoriasis
J Am Acad Dermatol
(1990)Immunity during cyclosporine therapy
J Am Acad Dermatol
(1990)- et al.
Acitretin versus etretinate in psoriasis
J Am Acad Dermatol
(1988) - et al.
Life-threatening psoriasis relapse on withdrawal of cyclosporine
Lancet
(1988) - et al.
Psoriasis and cyclosporin withdrawal
Lancet
(1988) - et al.
Treatment of resistant severe psoriasis with systemic cyclosporine
J Am Acad Dermatol
(1987) Renal effects of cyclosporine
J Am Acad Dermatol
(1990)- et al.
Cyclosporine therapy for psoriasis: serum creatinine measurements are an unreliable predictor of decreased renal function
J Am Acad Dermatol
(1989) - et al.
Morphologic renal changes during cyclosporine treatment of psoriasis
J Am Acad Dermatol
(1992)
Alterations in renal function in psoriasis patients treated with cyclosporine, 5 mg/kg/day
J Am Acad Dermatol
Hypertriglyceridemia in patients with psoriasis treated with cyclosporine
J Am Acad Dermatol
Elevation of fasting serum lipids in patients treated with low-dose cyclosporine for severe plaque-type psoriasis
J Am Acad Dermatol
Laboratory monitoring of cyclosporine levels: guidelines for the dermatologist
J Am Acad Dermatol
Cyclosporine improves psoriasis in a double-blind study
JAMA
Low-dose cyclosporin A in severe psoriasis: a double-blind study
Br J Dermatol
Cyclosporine for plaque-type psoriasis: results of a multidose, double-blind trial
N Engl J Med
A multicenter study of cyclosporin in the plaque form of psoriasis: an interim report
Short- and long-term considerations concerning the management of plaque psoriasis with low-dose cyclosporin
Dermatology
Predictive value of cyclosporin A level for efficacy or renal dysfunction in psoriasis
Br J Dermatol
Side-effect profile of cyclosporin A in patients treated for psoriasis
Br J Dermatol
Efficacy of low-dose cyclosporine A in psoriasis: results of dose-findings studies
Br J Dermatol
Low-dose cyclosporin A (1, 2 or 3 mg/kg/day) in a large series of moderate psoriasis patients: preliminary results [Abstract]
J Invest Dermatol
The pathomechanisms of psoriasis: the skin immunesystem and cyclosporin
Br J Dermatol
Mechanism of action and rationale for cyclosporin A in psoriasis
Br J Dermatol
The mode of action of cyclosporin
Drug Invest
Cyclosporine is angiostatic
Experientia
Rationale für eine Sandimmun-Therapie der Psoriasis
Z Hautkr
Cited by (154)
Nail Psoriasis
2022, Actas Dermo-SifiliograficasResearch on classification diagnosis model of psoriasis based on deep residual network
2021, Digital Chinese MedicineRecommendations for the definition, evaluation, and treatment of nail psoriasis in adult patients with no or mild skin psoriasis: A dermatologist and nail expert group consensus
2019, Journal of the American Academy of DermatologyCitation Excerpt :Acitretin should be initiated at 0.2-0.4 mg/kg for >6 months or until at least a moderate improvement is documented.38,56,61-64 Cyclosporine is only recommended for short-term treatment under monitoring (until moderate improvement has been documented) in doses of 3-5 mg/kg.63,65-70 Methotrexate can be employed in doses up to 15 mg/week, with proper monitoring, and with or without folic acid (according to the country's regulations) for the treatment of nail psoriasis until at least moderate improvement has been documented.38,56,62,63,70,71
Tips to Treat the 5 Most Common Nail Disorders. Brittle Nails, Onycholysis, Paronychia, Psoriasis, Onychomycosis.
2015, Dermatologic ClinicsCitation Excerpt :If the nail plate is thin and fragile, it is better not to use acitretin because it could worsen the condition. Subcutaneous methotrexate (15 mg per week) and a low dosage of oral cyclosporin (2.5 mg/kg/d) have also been used with success.37,38 The former seems to give better results for nail matrix psoriasis, the latter for nail bed psoriasis.
Computer-Aided Diagnosis Based on DenseNet201 Architecture for Psoriasis Classification
2024, EAI/Springer Innovations in Communication and ComputingSystemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
2023, Cochrane Database of Systematic Reviews